Japan-based Cyfuse Biomedical raises 1.4 billion yen ($12m) to support the development of 3D printing technology which can produce human tissue.
Cyfuse Biomedical, a developer of a 3D printer which can be used to print human tissue, has raised $12m.
The Japan-based firm was backed by early-stage university venturing fund University of Tokyo Edge Capital, venture firm Jafco, and robotic limb manufacturer Cyberdyne.
The company, founded in 2010, has developed a 3D printer which can print living cells as artificial human tissue. It is hoped that the technology could eventually be used to print out organs based on a patient’s own cells. Cyfuse is currently selling the 3D printer to Japanese universities to conduct research, and plans to start targeting overseas institutions this year.
Koji Kuchiishi, Cyfuse’s CEO, said: “Bio 3-D printing technology is going to push regenerative medicine forward. Someday we are going to see a world where we can regenerate body parts such as blood vessels, hearts and livers.”
